EUROLAB laboratory provides testing and compliance service within the scope of USP 711 standard. This test is provided to determine compliance with dissolution requirements set out in the separate monograph for orally administered dosage forms.
This general section has been harmonized with the relevant texts of the European Pharmacopoeia or the Japanese Pharmacopoeia. These pharmacopoeias have committed not to make any unilateral changes to this harmonized chapter.
In this general section, a dosage unit is defined as 1 tablet or 1 capsule, or the amount specified. Of the types of apparatus described here, use the one specified in the individual monograph.
Where a dissolution or degradation test is included in the individual monograph where the label indicates that an article is enteric-coated and does not specifically state that it will be applied to delayed-release articles, the procedure and interpretation given for Delayed-Release Dosage Forms apply unless otherwise stated.
EUROLAB assists manufacturers with USP 711 test compliance. Our test experts, with their professional working mission and principles, provide you, our manufacturers and suppliers, the best service and controlled testing process in our laboratories. Thanks to these services, businesses receive more effective, high-performance and quality testing services and provide safe, fast and uninterrupted service to their customers.
To get an appointment, to get more detailed information or to request an evaluation, you can ask us to fill in our form and reach you.
EUROLABreporting and certification activities, United Accreditation Foundation (UAF), Turkish Accreditation Agency (TÜRKAK) ve Enterprise Accreditation Foundation (EAF) based on the accreditation provided by the accreditation body. The Enterprise Accreditation Foundation (EAF) accreditation body is also a signatory of the United Nations (UN GLOBAL COMPACT) organization.
